A SMART Shift in Pediatric Asthma

In 2020, the expert panel of the National Asthma and Education Prevention Program recommended the use of single maintenance and reliever therapy consisting of inhaled corticosteroid-formoterol in a single inhaler for patients 4 years and older with moderate to severe persistent asthma not well controlled. Research has suggested single maintenance and reliever therapy is a more effective approach to managing asthma and effectively reduces the number of asthma exacerbations and oral corticosteroid use, providing better control and improved quality of life for children.
Source: The Journal for Nurse Practitioners - Category: Nursing Authors: Tags: Featured Article Source Type: research